The 8 semi-finalists are just announced in the AIM-HI Accelerator Fund's inaugural Women’s Venture Competition! These innovative oncology startups are selected from an exceptional pool of high quality women entrepreneur applications, by a Selection Committee comprised of world-class key opinion…
Imran Alibhai, Ph.D., is the CEO of Tvardi Therapeutics, a biopharmaceutical company developing breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. The National Foundation for Cancer Research and AIM-HI Accelerator Fund have been early financial supporters of…
Tvardi Therapeutics Inc., a privately held, clinical-stage biopharmaceutical portfolio company of the AIM-HI Accelerator Fund focused on the development of STAT3 inhibitors, announced today over $5 million in non-dilutive grants to support the ongoing validation and clinical development of its…
Paul B. Fisher, M.Ph., Ph.D., co-founded InterLeukin Combinatorial Therapies with hopes of developing a product that destabilizes and kills cancer cells. The Director of Virginia Commonwealth University’s Institute of Molecular Medicine, Fisher represents a world-class scientist with knowledge also of…
Rose Wang is a serial entrepreneur who helps other individuals and teams—including female cancer researchers—start their own businesses and make them thrive. Wang is the founder of Binary Group, a consulting and business solutions firm. She also currently serves as Executive…
The National Foundation for Cancer Research is a "special organization," says Charlie Weatherspoon, Co-founder and Chairman of the Board of the AIM-HI Accelerator Fund (AIM-HI), which has a strong relationship with NFCR. Weatherspoon contrasts the grassroots efforts at NFCR and…
Oncoheroes Biosciences, currently working on the clinical development of volasertib, a potential new drug for rhabdomyosarcoma patients, is honored to announce the receipt of funding from Super Sam Foundation, a pediatric cancer non-profit. Read more: https://oncoheroes.com/insights-news-1/2020/5/29/oncoheroes-biosciences-and-super-sam-foundation-walking-together-for-the-pediatric-cancer-heroes
Oncoheroes Biosciences, a biotech focused exclusively on advancing new therapies for children with cancer, receives another endorsement from a childhood cancer non-profit. The support received by The Gregory Foundation for Cancer Research will help accelerate the clinical drug development of…
Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng and Project Advances New Systems Biology Paradigm for Cancer Treatment World-First Phase II Multi-Regional Clinical Trial for a Botanical Cancer Drug Candidate ROCKVILLE, MD –…
Mr. Peikwen Cheng is Co-founder and CEO of Yiviva, a biotechnology start-up that develops first-in-class therapeutics. The company developed YIV906, an herbal mixture based on an 1,800-year-old Chinese formula. A number of clinical studies show YIV906 reduces the harmful adverse…
